Behind the strength of Taiji Group is a powerful scientific research system, which consists of Chongqing Institute of Traditional Chinese Medicine, Taiji Medicine Research Institute, postdoctoral workstation and five R&D centers.
Among them, Chongqing Institute of Traditional Chinese Medicine is the largest scientific research institution of traditional Chinese medicine in China, with more than 300,000 specimens of traditional Chinese medicine in the world, more than 50 mu of medicinal botanical gardens and 200,000 mu of Cordyceps bases in Kangding and Shiqu. It is estimated that the output of Cordyceps sinensis will reach 6,543.8+billion in 2008, which not only lays a foundation for the industrialization of traditional Chinese medicine, but also promotes the economic development in minority areas.
Taiji Group has also established postdoctoral workstations in cooperation with Peking University, Academy of Military Medical Sciences, China Pharmaceutical University and other national 15 universities, and now there are more than 40 postdoctoral workstations.
Taiji Group's R&D centers are all over the world: there are Beijing New Product Design Center, German Medical Information Center, American Medical Information Center, Sydney Chinese Medicine Research Center, Macau Taiji Co., Ltd. and other institutions responsible for new product design and scientific and technological information collection.
As we all know, the transformation of science and technology into productive forces will produce a qualitative leap, and Taiji Group is making a leap with advanced product research and development and advanced production technology.
It has the largest syrup production line in Asia, with an annual output of 1 100 million bottles; The largest oral liquid production line in China, with an annual output of 654.38+0 billion; The largest Chinese herbal medicine pretreatment workshop and extraction and concentration workshop in China, with an annual extraction capacity of 654.38+10,000 tons; China No.1 GMP sample production workshop freeze-dried powder injection production line.
It has the most advanced bottle-making production line in Japan, soft bag infusion production line in Germany, automatic granule production line in Canada and automatic packaging production line in Italy.
Taiji Group has gradually developed from a simple pharmaceutical enterprise into a large pharmaceutical group integrating R&D, production and sales.
Tongjunge Co., Ltd., a subsidiary of Tongjunge Co., Ltd., is the largest pharmaceutical commercial enterprise in western China, with the most perfect pharmaceutical commercial network in the west, and the first chain enterprise in China to pass GSP certification. More than 6,000 pharmacies and 1500 village-level drug counters radiate the domestic retail market. In 2005, the sales amounted to 5.2 billion yuan, with more than 20,000 operating standards and more than 600 famous products.
Beijing Tongjunge Pharmacy is located in Wangfujing Street, which is known as the "Golden Street". It covers an area of 2,500 square meters and operates more than 10000 varieties.
Taiji medical logistics system, with Chengdu Western Medicine Group as the core, includes two regional logistics centers in Chengdu and Chongqing, and Southwest 10 distribution center, which is the most developed medical logistics system in western China.
Easy to have Tai Chi is the second instrument; Four images and four images give birth to gossip. Taiji Group has put thousands of years of Taiji culture into practice and refined a set of Taiji marketing art: with "all-staff marketing" as the market killer, it has rapidly expanded its market share and sales network, with more than 3,000 salespeople, more than 500 general agents, more than 3,000 dealers, more than 4,000 hospital pharmacies and more than 0/00000 pharmacies.
The proud performance won the honor of "the first prize of national management achievement in 2000" for Taiji Group's "comprehensive and systematic marketing management".
For a long time, Taiji Group has introduced a number of well-known superior varieties with its unique advantages in resources, technology, equipment, talents and network, and enjoys a good reputation at home and abroad. The development of new drugs has formed a benign pattern of development generation, development generation and reserve generation.
Chinese and western drug varieties 1000. There are more than 50 varieties produced exclusively in China, 59 national invention patents, more than 30 protected varieties of traditional Chinese medicine and 6 varieties with annual sales exceeding 100 million yuan.
In particular, Qumei, which is popular in the market, is one of the two slimming drugs approved by the FDA in the past 30 years. The first slimming drug approved by SFDA in China has a safe and reliable curative effect, and its sales in the past five years have exceeded 654.38+0.8 billion yuan.
The sales of Bushen Yishou Capsule in 2005 exceeded 100 million yuan.
Huoxiang Zhengqi Oral Liquid 1997 won the China Patent Invention Gold Award jointly awarded by the World Intellectual Property and China Patent Office, and its sales in 2005 exceeded 100 million yuan.
In recent years, the sales revenue of Jizhi syrup has increased steadily, with sales exceeding 400 million yuan in 2005.
Tomato capsule protects prostate. 1 tomato capsule is equivalent to 3 kilograms of tomato, and its antioxidant capacity is 0/00 times that of vitamin e.
As a new generation of anticancer drugs, paclitaxel has relieved the suffering of countless cancer patients.
Tylenol was developed for 60 million diabetic patients in China. It is one of the most effective drugs for treating type 2 diabetes in the world at present, and it is also the only antidiabetic drug with independent intellectual property rights in China. In 2005, he won the "National Tenth Five-Year Major Scientific and Technological Achievement Award".
The product is an extension of Taiji's profound culture and the birth of Taiji people's "ideal of creating health and happiness for mankind and comprehensively improving the quality of life".
In management, the annual salary system is fully implemented, and at the same time, the way of "saving energy" is adopted, and the management personnel take turns to rest (either doing research, going to college for further study, or going abroad for inspection, and then taking turns after three to five years). In addition, Taiji Group is brave and good at "taking advantage of the situation", boldly using and integrating resources from all walks of life, "focusing on management with two eyes inward, focusing on the market with two hands outward, and conducting research with two feet downward", adhering to "high standards and strict requirements" in selecting, educating and employing people, and attaching importance to the cultivation of compound young talents. The company has formulated a series of systems and supporting measures to encourage employees to receive continuing education, and built a learning team by sending MBA, studying abroad and on-the-job training. Up to now, more than 200 people have studied for doctoral and master's degrees; More than 200 people went to the United States, Europe, Japan, Australia and other countries and regions for training and inspection.